Literature DB >> 15042020

Evidence of endothelial dysfunction in preeclampsia: decreased endothelial nitric oxide synthase expression is associated with increased cell permeability in endothelial cells from preeclampsia.

Yuping Wang1, Yang Gu, Yanping Zhang, David F Lewis.   

Abstract

OBJECTIVE: The purposes of this study were to examine endothelial nitric oxide synthase expression in endothelial cells and to determine whether the inhibition of endothelial nitric oxide synthase could impair endothelial barrier function in preeclampsia. STUDY
DESIGN: Messenger RNA and protein expression for endothelial nitric oxide synthase were examined in endothelial cells that were isolated from normal and preeclamptic pregnancies. Endothelial monolayer permeable response to interleukin-8 stimulation was determined. Normal endothelial cells that were treated with nitric oxide inhibitor were used to test the association of endothelial nitric oxide synthase and endothelial barrier function. Messenger RNA expression for endothelial nitric oxide synthase was determined by reverse transcription-polymerase chain reaction, and protein expression was determined by Western blot analysis. Endothelial permeability was measured by horseradish peroxidase leakage through endothelial cell filters. Interleukin-8 production was measured by enzyme-linked immunosorbent assay. Data were presented as mean+/-SE and analyzed by analysis of variance or nonparametric Mann-Whitney test.
RESULTS: Relative messenger RNA expression and protein expression for endothelial nitric oxide synthase were decreased significantly in endothelial cells from preeclampsia compared with cells from normal pregnancies (messenger RNA expression, 0.191+/-0.057 vs 0.508+/-0.061 [P <.01]; protein expression, 0.225+/-0.08 vs 0.786+/-0.098 [P<.01], respectively). Horseradish peroxidase leakage in normal endothelial cells was 0.30+/-0.26 micromol/L (interleukin-8, 1 pg/mL), 3.14+/-2.45 micromol/L (interleukin-8, 5 pg/ml), and 9.08+/-2.69 micromol/L (interleukin-8, 25 pg/mL; P<.01; compared with 0.77+/-0.47 micromol/L [control endothelial cells]). Horseradish peroxidase leakage in preeclamptic endothelial cells was 6.20+/-2.19 micromol/L, 8.44+/-85 micromol/L, and 15.79+/-2.06 micromol/L (P<.05) compared with 5.23+/-1.28 micromol/L, respectively. The ratio of horseradish peroxidase leakage was >7-fold increase in normal endothelial cells, but only a 4-fold increase in preeclamptic endothelial cells in response to interleukin-8 stimulation at 25 pg/mL. The inhibition of endothelial nitric oxide synthase with N(G)-Monomethyl-L-arginine resulted in an increase in interleukin-8-induced endothelial cell permeability. No difference for interleukin-8 production was observed between normal and preeclamptic endothelial cells (1.15+/-0.21 ng/mg protein vs 1.29+/-0.23 ng/mg protein, P>.5).
CONCLUSION: Increased endothelial permeability may be associated with decreased endothelial nitric oxide synthase expression and activity in endothelial cells from preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15042020     DOI: 10.1016/j.ajog.2003.09.049

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  24 in total

1.  The NOX2-derived reactive oxygen species damaged endothelial nitric oxide system via suppressed BKCa/SKCa in preeclampsia.

Authors:  Jie Chen; Qinqin Gao; Lin Jiang; Xueqin Feng; Xiaolin Zhu; Xiaorong Fan; Caiping Mao; Zhice Xu
Journal:  Hypertens Res       Date:  2017-01-12       Impact factor: 3.872

2.  Sexual Dimorphisms of Preeclampsia-Dysregulated Transcriptomic Profiles and Cell Function in Fetal Endothelial Cells.

Authors:  Chi Zhou; Qin Yan; Qing-Yun Zou; Xin-Qi Zhong; Chanel T Tyler; Ronald R Magness; Ian M Bird; Jing Zheng
Journal:  Hypertension       Date:  2019-06-03       Impact factor: 10.190

3.  Increased superoxide generation and decreased stress protein Hsp90 expression in human umbilical cord vein endothelial cells (HUVECs) from pregnancies complicated by preeclampsia.

Authors:  Yang Gu; David F Lewis; Yanping Zhang; Lynn J Groome; Yuping Wang
Journal:  Hypertens Pregnancy       Date:  2006       Impact factor: 2.108

4.  Elevated maternal soluble Gp130 and IL-6 levels and reduced Gp130 and SOCS-3 expressions in women complicated with preeclampsia.

Authors:  Yuping Wang; David F Lewis; Yang Gu; Shuang Zhao; Lynn J Groome
Journal:  Hypertension       Date:  2010-12-20       Impact factor: 10.190

5.  Vitamin D improves the angiogenic properties of endothelial progenitor cells.

Authors:  M Grundmann; M Haidar; S Placzko; R Niendorf; N Darashchonak; C A Hubel; F von Versen-Höynck
Journal:  Am J Physiol Cell Physiol       Date:  2012-08-29       Impact factor: 4.249

6.  Differential Distribution of Tryptophan-Metabolites in Fetal and Maternal Circulations During Normotensive and Preeclamptic Pregnancies.

Authors:  Ying-Jie Zhao; Chi Zhou; Ying-Ying Wei; Hui-Hui Li; Wei Lei; Derek S Boeldt; Kai Wang; Jing Zheng
Journal:  Reprod Sci       Date:  2021-10-07       Impact factor: 3.060

7.  Placental expression profiling in preeclampsia: local overproduction of hemoglobin may drive pathological changes.

Authors:  Magnus Centlow; Piero Carninci; Krisztian Nemeth; Eva Mezey; Michael Brownstein; Stefan R Hansson
Journal:  Fertil Steril       Date:  2007-12-31       Impact factor: 7.329

8.  Role of DNA methyltransferase 1 on the altered eNOS expression in human umbilical endothelium from intrauterine growth restricted fetuses.

Authors:  Bernardo J Krause; Paula M Costello; Ernesto Muñoz-Urrutia; Karen A Lillycrop; Mark A Hanson; Paola Casanello
Journal:  Epigenetics       Date:  2013-07-18       Impact factor: 4.528

Review 9.  Role of nitric oxide in placental vascular development and function.

Authors:  B J Krause; M A Hanson; P Casanello
Journal:  Placenta       Date:  2011-07-27       Impact factor: 3.481

10.  Circulating endothelial cells (CECs) and E-selectin: Predictors of preeclampsia.

Authors:  Ferdous Mehrabian; Sayed Mohammad Hashemi Jazi; Shaghayegh Haghjooy Javanmard; Mahshid Kaviani; Vida Homayouni
Journal:  J Res Med Sci       Date:  2012-01       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.